BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3333144)

  • 1. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cross-over study on therapy indicators and blood pressure lowering action of beta-receptor blocker atenolol and the diuretic combination triamterene/hydrochlorothiazide].
    Walter U; Cordes U; Philipp T; Distler A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():311-4. PubMed ID: 347804
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
    Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
    Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
    Zawada ET
    Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo controlled double-blind randomised cross-over trial of atenolol, hydrochlorothiazide and amiloride, and the combination (Kalten) in patients over 60 years of age.
    Jackson G; Rowland M; Adam G; MacFarlane E; Jackson PG
    Br J Clin Pract; 1986 Jun; 40(6):230-4. PubMed ID: 3527246
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing hypertension in family practice: a nationwide collaborative study of the use of four antihypertensives in the treatment of mild-to-moderate hypertension. A report from CEN. Clinical Experience Network.
    J Am Board Fam Pract; 1989; 2(3):172-90; discussion 190. PubMed ID: 2546375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrochlorothiazide/triamterene combination: once daily in the treatment of hypertension.
    Zacharias FJ; Cornhill J
    Br J Clin Pract; 1984 May; 38(5):185-7. PubMed ID: 6733013
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperkalemia in diabetes mellitus. Effect of a triamterene-hydrochlorothiazide combination.
    Hollenberg NK; Mickiewicz C
    Arch Intern Med; 1989 Jun; 149(6):1327-30. PubMed ID: 2730251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enalapril, atenolol and hydrochlorothiazide in mild or moderate hypertension. A comparative multicenter trial in general practice in Norway].
    Helgeland A; Strømmen R; Hagelund CH; Tretli S
    Tidsskr Nor Laegeforen; 1987 Nov; 107(33):2937-40, 2968. PubMed ID: 2829383
    [No Abstract]   [Full Text] [Related]  

  • 11. [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].
    Düsing R; Kramer HJ
    Dtsch Med Wochenschr; 1977 Oct; 102(43):1541-6. PubMed ID: 913294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
    Cocke TB; Fisch S; Gilmore HR; Okun R; Tamagna IG; Wipplinger K
    J Clin Pharmacol; 1977; 17(5-6):334-8. PubMed ID: 323298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
    Casner PR; Dillon KR
    J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triamterene nephrolithiasis complicating dyazide therapy.
    Patel KM
    J Urol; 1981 Aug; 126(2):230. PubMed ID: 7265370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive and metabolic effects of single and combined atenolol regimens.
    Chrysant SG; Chappel C; Farnham DJ; Levin B; Lueg M; McCluskey D; Steiner C
    J Clin Pharmacol; 1992 Jan; 32(1):61-5. PubMed ID: 1740538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hypertension with a fixed calcium antagonist-diuretic combination. Observations from treatment of 5,595 patients].
    Klaus D
    Fortschr Med; 1995 Mar; 113(7):90-6. PubMed ID: 7750891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene].
    Gonska BD; Kreuzer H
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1812-6. PubMed ID: 3905326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril versus hydrochlorothiazide/triamterene in mild-to-moderate hypertension in the elderly.
    Woo J; Woo KS; Vallance-Owen J
    Lancet; 1986 Oct; 2(8512):924. PubMed ID: 2876357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.